Middle East Pharmaceutical Industries Company vs Saudi Chemical Co.
A head-to-head of Middle East Pharmaceutical Industries Company (4016) and Saudi Chemical Co. (2230) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
Middle East Pharmaceutical Industries Company
4016
60.45 SAR
-0.74%
VS
Saudi Chemical Co.
2230
8.46 SAR
+0.12%
| Metric | 4016 | 2230 |
|---|---|---|
| Market Cap | 2.06B SAR | 7.13B SAR |
| P/E (TTM) | 12.46 | 21.15 |
| Forward P/E | 11.57 | — |
| P/S | 4.19 | 1.02 |
| P/B | 5.07 | 2.89 |
| EV/EBITDA | 9.59 | 16.19 |
| Dividend Yield | 2.39% | 1.18% |
| Profit Margin | 21.19% | 4.89% |
| Gross Margin | 62.29% | 12.43% |
| Operating Margin | 23.74% | 6.96% |
| Revenue Growth (YoY) | +33.65% | +5.05% |
| FCF Yield | 1.62% | 9.65% |
| Debt / Equity | 19.87 | 45.34 |
| Current Ratio | 2.85 | 1.40 |
Which is better: Middle East Pharmaceutical Industries Company or Saudi Chemical Co.?
- ✓Larger by market cap: Saudi Chemical Co.
- ✓Cheaper valuation (lower P/E): Middle East Pharmaceutical Industries Company
- ✓Higher dividend yield: Middle East Pharmaceutical Industries Company
- ✓More profitable (net margin): Middle East Pharmaceutical Industries Company
- ✓Faster revenue growth: Middle East Pharmaceutical Industries Company
- ✓Higher free-cash-flow yield: Saudi Chemical Co.
Across 12 available metrics, Middle East Pharmaceutical Industries Company leads 9–3.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Middle East Pharmaceutical Industries Company with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.